SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: RT who wrote (2642)11/19/1997 10:45:00 AM
From: Mark A. Stang  Respond to of 23519
 
You are not alone in thinking the Shah of I-wrong is a meathead.

Last fall in Money Magazine he pronounced Ivax grossly undervalued and set a target of around $22.



To: RT who wrote (2642)11/19/1997 11:54:00 AM
From: EyeDrMike  Read Replies (1) | Respond to of 23519
 
<< He also compared the ED products to rogaine. I don't believe thats an accurate comparision. >>

was there any implication that MUSE may someday be OTC?

Mike